Physician profile
Benjamin Schlechter
NPI 1689676470
$1,726.32
in general payments reported to CMS, 2019-2025
11 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $31.16 · 2021: $47.45 · 2022: $92.33 · 2023: $217 · 2024: $163 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.99 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.37 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $377.79 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $288.04 | 2025 | |
| Motiva USA, LLC | $158.23 | 2025 | |
| Mentor Worldwide LLC | $144.41 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $65.95 | 2019-2024 | |
| Arteriocyte Medical Systems, INC. | $50.72 | 2019 | |
| Sientra, INC. | $49.74 | 2019 | |
| Revance Therapeutics, INC. | $42.66 | 2025 | Daxxify |
| Baxter Healthcare | $38.71 | 2023 | |
| Organogenesis INC. | $13.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Schlechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.